Mn(III) Porphyrin, MnTnBuOE-2-PyP5+, Commonly Known as a Mimic of Superoxide Dismutase Enzyme, Protects Cardiomyocytes from Hypoxia/Reoxygenation Induced Injury via Reducing Oxidative Stress
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076159 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sudha Sharma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences-Shreveport, Shreveport, LA 71103, USA. Hauptthemen laut MEDLINE: Superoxide Dismutase, Myocytes, Cardiac, Oxidative Stress, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Lung and Blood Institute, NIAAA NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Myocardial ischemia-reperfusion injury (I/R) causes damage to cardiomyocytes through oxidative stress and apoptosis. We investigated the cardioprotective effects of MnTnBuOE-2-PyP5+ (BMX-001), a superoxide dismutase mimic, in an in vitro model of I/R injury in H9c2 cardiomyocytes. We found that BMX-001 protected against hypoxia/reoxygenation (H/R)-induced oxidative stress, as evident by a significant reduction in intracellular and mitochondrial superoxide levels. BMX-001 pre-treatment also reduced H/R-induced cardiomyocyte apoptosis, as marked by a reduction in TUNEL-positive cells. We further demonstrated that BMX-001 pre-treatment significantly improved mitochondrial function, particularly O2 consumption, in mouse adult cardiomyocytes subjected to H/R. BMX-001 treatment also attenuated cardiolipin peroxidation, 4-hydroxynonenal (4-HNE) level, and 4-HNE adducted proteins following H/R injury. Finally, the pre-treatment with BMX-001 improved cell viability and lactate dehydrogenase (LDH) activity in H9c2 cells following H/R injury. Our findings suggest that BMX-001 has therapeutic potential as a cardioprotective agent against oxidative stress-induced H/R damage in H9c2 cardiomyocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences-Shreveport, Shreveport, LA 71103, USA.
- Department of Radiation Oncology, Duke University School of Medicine, Durham, NC 27710, USA.
- Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.
- Pharmacokinetics/Pharmacodynamics (PK/PD) Core Laboratory, Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.
ORCID-Profile: Susmita Bhattarai, Ines Batinic-Haberle, Manikandan Panchatcharam
Förderung
- National Heart Lung and Blood Institute
- NIAAA NIH HHS
- NIGMS NIH HHS
- Louisiana State University Health Sciences-Shreveport Intramural Grant
- National Institutes of Health
Zitieren
APA
Sharma, S., Sharma, P., Subedi, U., Bhattarai, S., Miller, C., Manikandan, S., Batinic-Haberle, I., Spasojevic, I., Sun, H., Panchatcharam, M., & Miriyala, S. (2023). Mn(III) Porphyrin, MnTnBuOE-2-PyP5+, Commonly Known as a Mimic of Superoxide Dismutase Enzyme, Protects Cardiomyocytes from Hypoxia/Reoxygenation Induced Injury via Reducing Oxidative Stress. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076159
Vancouver
Sharma S, Sharma P, Subedi U, Bhattarai S, Miller C, Manikandan S, et al. Mn(III) Porphyrin, MnTnBuOE-2-PyP5+, Commonly Known as a Mimic of Superoxide Dismutase Enzyme, Protects Cardiomyocytes from Hypoxia/Reoxygenation Induced Injury via Reducing Oxidative Stress. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076159
BibTeX
@article{Sharma2023,
author = {Sharma, Sudha and Sharma, Papori and Subedi, Utsab and Bhattarai, Susmita and Miller, Chloe and Manikandan, Shrivats and Batinic-Haberle, Ines and Spasojevic, Ivan and Sun, Hong and Panchatcharam, Manikandan and Miriyala, Sumitra},
title = {Mn(III) Porphyrin, MnTnBuOE-2-PyP5+, Commonly Known as a Mimic of Superoxide Dismutase Enzyme, Protects Cardiomyocytes from Hypoxia/Reoxygenation Induced Injury via Reducing Oxidative Stress},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076159}
}
EUVIMED